C001 Conquer the Boards: Core Exam & Review
DESCRIPTION
This Certification Exam Prep Course is a hands-on experience where attendees take a simulated, at home, shortened version of the American Board of Dermatology certification CORE exams. The at home exam is designed to increase their comfort with the exam format, while practicing time management, and identifying areas of weakness in their knowledge base. During the sessions at the Annual Meeting, expert faculty will review the answers of the exam, providing high yield information for the certification CORE exams. Residents attending this course should walk away with a better understanding of the pace and structure of the exam. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Identify strengths and weaknesses in one’s knowledge base for the CORE exams and review high-yield exam relevant material.
Participants will acquire experience with the format of the CORE exams.
Participants will implement time management techniques pertinent to a timed exam.
SCHEDULE
9:00 AM
Introduction
Jennifer Lucas, MD, FAAD
9:05 AM
Medical Dermatology
Misha Rosenbach, MD, FAAD
9:17 AM
Dermatopathology
Allen Gordon Strickler, MD, PhD, MPH, FAAD
9:29 AM
Medical Dermatology
Roman Bronfenbrener, MD, FAAD
9:41 AM
Cosmetic/Procedural Dermatology
9:53 AM
Medical Dermatology
Jeffrey Marcus Cohen, MD, FAAD
10:17 AM
Pediatric Dermatology
Luke Samuel Johnson, MD, FAAD
10:17 AM
Dermatopathology
Julia S. Lehman, MD, FAAD
10:29 AM
Medical Dermatology
Steven T. Chen, MD, MPH, FAAD
10:41 AM
Surgical Dermatology
Basia M Michalski, MD, FAAD
10:53 AM
Pediatric Dermatology
JiaDe Yu, MD, FAAD
11:05 AM
Medical Dermatology
Jonathan Scott Leventhal, MD, FAAD
11:17 AM
Dermatopathology
Michelle B Tarbox, MD, FAAD
11:29 AM
Medical Dermatology
11:41 AM
Surgical Dermatology
Jennifer Lucas, MD, FAAD
DIRECTOR
Jennifer Lucas, MD, FAAD
SPEAKERS
Roman Bronfenbrener, MD, FAAD
Steven T. Chen, MD, MPH, FAAD
Raj J Chovatiya, MD, PhD, FAAD
Jeffrey Marcus Cohen, MD, FAAD
Luke Samuel Johnson, MD, FAAD
Julia S. Lehman, MD, FAAD
Jonathan Scott Leventhal, MD, FAAD
Basia M Michalski, MD, FAAD
Misha Rosenbach, MD, FAAD
Allen Gordon Strickler, MD, PhD, MPH, FAAD
Michelle B Tarbox, MD, FAAD
Mara C Weinstein Velez, MD, FAAD
JiaDe Yu, MD, FAAD
DISCLOSURES
Roman Bronfenbrener, MD, FAAD
No financial relationships exist with ineligible companies.
Steven T. Chen, MD, MPH, FAAD
AbbVie – Advisory Board(Honoraria); Vertex Pharmaceuticals Incorporated – Employee (w-2 relationship)(Salary); VisualDx – Independent Contractor(Fees);
Raj J Chovatiya, MD, PhD, FAAD
AbbVie – Consultant(Fees), Speaker(Honoraria); Acelyrin – Consultant (1099 relationship)(Fees); Alumis – Consultant (1099 relationship)(Fees); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant(Fees); Arcutis Biotherapeutics – Consultant(Fees), Speaker(Fees); arGEN-X – Consultant(Fees); ASLAN Pharmaceuticals – Consultant(Fees); Astria Therapeutics – Consultant (1099 relationship)(Fees); Avalere Health – Consultant (1099 relationship)(Honoraria); Beiersdorf, Inc. – Consultant(Fees), Speaker(Fees); Boehringer Ingelheim – Consultant(Fees), Speaker(Honoraria); Bristol-Myers Squibb – Consultant(Fees), Speaker(Honoraria); Cara Therapeutics – Consultant(Fees); Castle Biosciences – Consultant (1099 relationship)(Fees); Dermavant Sciences – Consultant(Fees), Speaker(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Fees); EMD Serono – Consultant (1099 relationship)(Fees); Formation Bio – Consultant (1099 relationship)(Fees); Foundation for Research & Education of Dermatology – Speaker/Faculty Education(Honoraria); Galderma – Consultant (1099 relationship)(Fees), Speaker(Fees); Genentech, Inc. – Consultant(Fees); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Fees); Kenvue – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc. – Consultant(Fees), Speaker(Fees); Maui Derm – Speaker/Faculty Education(Honoraria); National Eczema Association – Speaker/Faculty Education(Honoraria); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Novartis – Speaker(Fees); Opsidio – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Fees), Speaker(Fees); RAPT Therapeutics – Consultant (1099 relationship)(Fees); Regeneron – Consultant(Fees), Speaker(Fees); Sanofi – Consultant(Fees), Speaker(Fees); Sitryx – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); TRex Bio – Consultant (1099 relationship)(Fees); UCB – Consultant(Fees), Speaker(Honoraria);
Jeffrey Marcus Cohen, MD, FAAD
Advarra – Data Safety Monitoring Board(Fees); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Honoraria); Imagene Bio – Consultant (1099 relationship)(Honoraria); Johnson & Johnson – Advisory Board(Honoraria); JORA Immunology – Founder(Stock); Logical Images, Inc – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria);
Luke Samuel Johnson, MD, FAAD
Incyte Corporation – Other(Grants/Research Funding); Organon Biosciences SRL – Other(Grants/Research Funding); Pierre Fabre – Other(Grants/Research Funding);
Julia S. Lehman, MD, FAAD
No financial relationships exist with ineligible companies.
Jonathan Scott Leventhal, MD, FAAD
Azitra, Inc – Investigator(Grants/Research Funding); La Roche Posay Dermatologique – Advisory Board(Honoraria); OnQuality Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria);
Jennifer Lucas, MD, FAAD
Abbott Pharmaceuticals – Stockholder(Stock); Regeneron Pharmaceuticals, Inc. – Stockholder(Stock);
Basia M Michalski, MD, FAAD
No financial relationships exist with ineligible companies.
Misha Rosenbach, MD, FAAD
Google Ventures – Consultant (1099 relationship)(Honoraria); J&J Innovative Medicine – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); OpenEvidence – Advisory Board(Other Financial Benefit); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding);
Allen Gordon Strickler, MD, PhD, MPH, FAAD
No financial relationships exist with ineligible companies.
Michelle B Tarbox, MD, FAAD
AbbVie – Advisory Board(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding); Dermaleve – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Leo Pharma – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria); Sanofi/Regeneron – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Mara C Weinstein Velez, MD, FAAD
Allergan, Inc – Investigator(Honoraria); Beiersdorf, Inc. – Other(Honoraria); Merz Aesthetics – Investigator(Honoraria);
JiaDe Yu, MD, FAAD
American Contact Dermatitis Society – Board of Directors(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Dermavant Sciences – Speaker/Faculty Education(Honoraria); Incyte – Advisory Board(Honoraria); L'Oreal – Consultant (1099 relationship)(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Leo Pharma – Advisory Board(Honoraria); National Eczema Association – Consultant(Fees), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria);